Skip to content
10-K

Annual Report

Raphael Pharmaceutical Inc. RAPH

0001213900-26-037402

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 31, 2026 20.18M sh
Shares Diluted FY 2025 · Dec 31, 2025 19.55M sh
Shares Diluted FY 2025 · Dec 31, 2024 18.67M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$210K
Operating Cash Flow FY 2025 · Dec 31, 2024 −$532K
Stockholders Equity FY 2025 · Dec 31, 2025 −$1.43M
Stockholders Equity FY 2025 · Dec 31, 2024 −$742K
Stockholders Equity restated FY 2025 · Dec 31, 2023 $107K
Current Liabilities FY 2025 · Dec 31, 2025 $1.49M
Current Liabilities FY 2025 · Dec 31, 2024 $769K
Current Assets FY 2025 · Dec 31, 2025 $51K
Current Assets FY 2025 · Dec 31, 2024 $25K
Total Assets FY 2025 · Dec 31, 2025 $53K
Total Assets FY 2025 · Dec 31, 2024 $27K
Eps Diluted FY 2025 · Dec 31, 2025 $0.07
Eps Diluted FY 2025 · Dec 31, 2024 $0.08
Eps Basic FY 2025 · Dec 31, 2025 $0.07
Eps Basic FY 2025 · Dec 31, 2024 $0.08
Sga Expense FY 2025 · Dec 31, 2025 $614K
Sga Expense FY 2025 · Dec 31, 2024 $733K
Rd Expense FY 2025 · Dec 31, 2025 $631K
Rd Expense FY 2025 · Dec 31, 2024 $776K
Net Income FY 2025 · Dec 31, 2025 −$1.28M
Net Income FY 2025 · Dec 31, 2024 −$1.52M
Operating Income FY 2025 · Dec 31, 2025 −$1.25M
Operating Income FY 2025 · Dec 31, 2024 −$1.51M
Stock Issued restated FY 2025 · May 31, 2024 350K sh
Stock Issued FY 2025 · Jun 30, 2023 170.38K sh